Log in to save to my catalogue

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1...

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1125237841

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

About this item

Full title

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

Publisher

New York: Nature Publishing Group US

Journal title

Cancer gene therapy, 2012-11, Vol.19 (11), p.773-778

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

MicroRNA-155 (miR-155) overexpression is often found in malignancies including lung cancer. The objective of this study is to verify the hypothesis, based on the results of bioinformatics analysis, that miR-155 modulates cellular apoptosis and DNA damage through the regulation of Apaf-1 and is thus involved in the development and progression of lun...

Alternative Titles

Full title

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1125237841

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1125237841

Other Identifiers

ISSN

0929-1903,1476-5500

E-ISSN

1476-5500

DOI

10.1038/cgt.2012.60

How to access this item